GC MediAIGC메디아이

GC MediAI's trailing results have swung back to a small net loss on thin margins, while the shares trade well below their 52-week high.

GC MediAI sells EMR and practice-management software to clinics and pharmacies in Korea, and also runs healthcare analytics, medical device distribution and automated dispensing equipment. For the twelve months to H1 2026 it reported revenue of about ₩205B and operating income of about ₩12B, but a net loss of about ₩1.7B. The share price is ₩3,000, down 20.6% over one year, with a market cap of about ₩157B.

What stands out

• Trailing revenue of ₩205B is up from ₩198B in 2025, but operating margin of 5.9% is above the 3.8% reported for 2025 while net margin is slightly negative at -0.8%.
• The 2025 net income of ₩37B was far above operating income of ₩7.5B, which the data does not explain; the trailing figure has since turned to a loss.
• Cash of ₩13.7B against borrowings of ₩7.3B and a liabilities-to-equity ratio of 43.7% give a moderate balance sheet picture; trailing free cash flow is ₩18.8B.
• Valuation metrics show a price-to-book of 1.1 and an EV/EBITDA of 9, with no meaningful trailing P/E because of the net loss; the data includes a 1.7% dividend yield.
• A discounted cash flow model in the data gives a base value of ₩3,114, below the ₩3,000 close only slightly, with bear and bull cases of ₩1,251 and ₩6,381.

What to watch

• A change of largest shareholder and a 5%+ holding report were both filed on 19 October 2026; the filings do not describe the reasons or the new holder's plans in the data provided.
• Whether the company returns to a net profit in upcoming results, since trailing net income is negative while operating income is positive.
• The data includes no recent news headlines, and no analyst ratings or price targets are provided.